Filter posts

Head of Japan’s Drug Regulatory Authority Will Keynote BIO Asia

Since taking the role of chief executive of the Pharmaceuticals and Medical Devices Agency (PMDA) …

BIO 2019 Start-Up Stadium – Changing the World from the Ground Up

The Biotechnology Innovation Organization (BIO) is proud to announce its Start-Up Stadium program at #BIO2019, …

Win a Complimentary Company Presentation & Registration at #BIO2019

Are you an innovative biotech company that is R&D-intensive and is developing strategic partnerships within …

With an Air of Optimism, #BIOCEO19 Concludes

Despite considerable pressure directed squarely at biotech innovators from politicians of every stripe, biotech executives …

#BIOCEO19: Navigating Payers’ Expectations for Value-Based Agreements

Value-based agreements are becoming increasingly important in the biopharmaceutical reimbursement space, particularly as new advanced …

Market Outlook—Leveraging Market Corrections for M&A or IPOs

After a multi-year expansion of company formation and in biopharma valuations, 2018 was a year …

#BIOCEO19 Kicks Off in NYC

Pharmaceutical innovation is not slowing down. Last year the FDA approved a total of 59 …

Meet Kallyope’s Nancy Thornberry, Fireside Chat Speaker at #BIOCEO19

Biotech startups come in all shapes, sizes and approaches but have one thing in common: …

Meet Synlogic’s Aoife Brennan, Fireside Chat Speaker at #BIOCEO19

Dr. Aoife Brennan has always faced challenges head-on. A trained endocrinologist, she could have remained …

Using Decision Science for Negotiations: Getting to Win-Win

New medicines often progress from idea to regulatory approval through collaborative licensing agreements or acquisition.  …